Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years

Journal of the American College of Cardiology

Volumn 28, Issue 3, 1996, Pages 616-626

  FitzGibbon, Gerald M ^a,b   Kafka, Henryk P ^a   Leach, Alan J ^a   Keon, Wilbert J ^a   Hooper, G David ^a   Burton, Jeffrey R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b National Defence Medical Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; SURVIVAL;

ADULT; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0030245599     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00206-9     Document Type: Article

References (73)

1. 1. Nwasokwa ON. Coronary artery bypass graft disease. Ann Intern Med 1995;123:528-45.
2. 2. FitzGibbon GM, Burton JR, Leach AJ. Coronary bypass graft fate. Angiographic grading of 1400 consecutive grafts early after operation and of 1132 after one year. Circulation 1978;57:1070-4.
3. 3. FitzGibbon GM; Leach AJ, Keon WJ, Burton JR, Kafka HP. Coronary bypass graft fate. Angiographic study of 1,179 vein grafts early, one year, and five years after operation. J Thorac Cardiovasc Surg 1986;91:773-8.
4. 4. FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate; long-term angiographic study. J Am Coll Cardiol 1991;17:1075-80.
5. 5. Vineberg A. Internal mammary artery implant in the treatment of angina pectoris - a three year follow-up. Can Med Assoc J 1954;70:367-78.
6. 6. Favaloro RG, Effler DB, Groves LK, Sones FM Jr, Fergusson BJG. Myocardial revascularization by internal mammary artery implant procedures. J Thorac Cardiovasc Surg 1967;54:359-70.
7. 7. FitzGibbon GM, Kafka HP, Leach AJ, Burton JR. Interventions for coronary stenosis. A Canadian experience of 30 revolutionary years. Can J Cardiol. In press.
8. 8. FitzGibbon GM, Keon WJ. Shared care for open heart surgery: 21 years' experience. Can J Cardiol 1996;12:59-64.
9. 9. Gray C. Canada's main military hospital on sick list because of federal budget cuts. Can Med Assoc J 1994;150:1655-6.
10. 10. FitzGibbon GM, Hamilton MG, Leach AJ, Kafka HP, Markle HV, Keon WJ. Coronary artery disease and coronary bypass grafting in young men: experience with 138 subjects 39 years of age and younger. J Am Coll Cardiol 1987;9:977-88.
11. 11. Galbut DL, Traad EA, Dorman MJ, et al. Seventeen-year experience with bilateral internal mammary artery grafts. Ann Thorac Surg 1990;49:195-201.
12. 12. Cameron AAC, Green GE, Brogno DA, Thornton J. Internal thoracic artery grafts: 20-year clinical follow-up. J Am Coll Cardiol 1995;25:188-92.
13. 13. Kieser TM, FitzGibbon GM, Keon WJ. Sequential coronary bypass grafts. Long-term follow-up. J Thorac Cardiovasc Surg 1986;91:767-72.
14. 14. Grondin CM. Graft disease in patients with coronary bypass grafts. Why does it start? Where do we stop? [editorial]. J Thorac Cardiovasc Surg 1986;92:323-9.
15. 15. Kafka H, FitzGibbon GM, Leach AJ. Aortocoronary vein graft spasm during angiography. Can J Cardiol 1995;11:211-6.
16. 16. Morton BC, Higginson LA, Beanlands DS. Death in the catheterization laboratory. Can Med Assoc J 1993;149:165-9.
17. 17. FitzGibbon GM, Keon WJ, Burton JR. Aorta-coronary bypass in patients with coronary artery disease who do not have angina. J Thorac Cardiovasc Surg 1984;87:717-24.
18. 18. Colton T. Statistics in Medicine. Boston: Little, Brown, 1974.
19. 19. Burton JR, FitzGibbon GM, Keon WJ, Leach AJ. Perioperative myocardial infarction complicating coronary bypass. J Thorac Cardiovasc Surg 1981;82: 758-64.
20. 20. Heggtveit HA, Lobo FV. Atherosclerosis in internal mammary arteries selected for coronary artery bypass grafting. Can J Cardiol 1992;8:50-2.
21. 21. Life Tables 1980-82. Publication 84-352. Ottawa: Statistics Canada, 1984.
22. 22. Gertler MM, White PD, Simon R, Gottsch LG. Long-term follow-up study of young coronary patients. Am J Med Sci 1964;247:145-55.
23. 23. FitzGibbon GM, Kafka HP, Keon WJ. Aorta-coronary bypass in patients with coronary artery disease who do not have angina: a brief follow-up 15 years after the last case reported [letter]. J Thorac Cardiovasc Surg 1995;110:1155-7.
24. 24. FitzGibbon GM, Keon WJ. Atheroembolic perioperative infarction during repeat coronary bypass surgery: angiographic documentation in a survivor. Ann Thorac Surg 1987;43:218-9.
25. 25. Bulkley BH, Ross RS. Coronary-artery bypass surgery: it works, but why? [editorial]. Ann Intern Med 1978;88:835-6.
26. 26. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easlay K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89: 248-58.
27. 27. Bourassa MG. Fate of venous grafts: the past, the present and the future [editorial]. J Am Coll Cardiol 1991;17:1081-3.
28. 28. Lie JT, Lawrie GM, Morris GC. Aortocoronary bypass saphenous vein graft atherosclerosis: anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol 1977;40:906-14.
29. 29. Solymoss BC, Leung TK, Pelletier LC, Campeau L. Pathologic changes in coronary artery saphenous vein grafts and related etiologic factors. In: Waters DD, Bourassa MG, editors. Care of the Patient with Previous Coronary Bypass Surgery. Cardiovascular Clinics. Philadelphia: FA Davis, 1991:45-65.
30. 30. Barboriak JJ, Batayias GE, Pintar K, Korns ME. Pathological changes in surgically removed aortocoronary vein grafts. Ann Thorac Surg 1976;21: 524-7.
31. 31. Bulkey BH, Hutchins GM. Accelerated "atherosclerosis." A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation 1977;55:163-9.
32. 32. Kalan JM, Roberts WC. Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than one year: necropsy analysis of 53 patients, 123 saphenous veins. Am Heart J 1990;119:1164-84.
33. 33. Grondin CM. Late results of coronary artery grafting: is there a flag on the field? J Thorac Cardiovasc Surg 1984;87:161-6.
34. 34. Neitzel GF, Barboriak KP, Qureshi I. Atherosclerosis in aortocoronary bypass grafts: morphologic study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis 1986;6:594-600.
35. 35. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989;79 Suppl I:I-24-9.
36. 36. Lytle BW, Loop FD, Taylor PC, et al. Vein graft disease: The clinical impact of stenosis in saphenous bypass vein grafts to coronary arteries. J Thorac Cardiovasc Surg 1992;103:831-40.
37. 37. Grondin CM, Thornton JC. The natural history of saphenous vein grafts. In: Lüscher TF, Turina M, Braunwald E, editors. Coronary Artery Graft Disease. Mechanisms and Prevention. Berlin, Heidelberg, New York: Springer-Verlag, 1995:3-15.
38. 38. Solymoss BC, Nadeau P, Millette D, Ing B, Campeau L. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation 1988;78 Suppl I:I-140-3.
39. 39. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:563-73.
40. 40. Falk E. Why do plaques rupture? Circulation 1992;86 Suppl III:III-30-42.
41. 41. Walts AE, Fishbein MC, Sustaita H, Matloff JM. Ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: a mechanism of acute, thrombotic, late graft occlusion. Circulation 1982;65:197-201.
42. 42. Kafka H. Repeated plaque rupture in the same bypass graft. Can J Cardiol 1993;9:654-6.
43. 43. Grondin CM, Pomar JL, Hebert Y, et al. Reoperation in patients with patent atherosclerotic coronary vein grafts, a different approach to a different disease. J Thorac Cardiovasc Surg 1984;87:379-85.
44. 44. Grondin CM, Campeau L, Lespérance J, et al. Atherosclerotic changes in coronary vein grafts six years after operation. J Thorac Cardiovasc Surg 1979;77:24-31.
45. 45. Grondin CM, Lespérance J, Bourassa MG, Pasternac A, Campeau L, Grondin P. Serial angiographic evaluation in 60 consecutive patients with aorto-coronary artery vein grafts 2 weeks, 1 year, and 3 years after operation. J Thorac Cardiovasc Surg 1974;67:1-6.
46. 46. Campeau L, Enjalbert M, Lespérance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 1983;68 Suppl II:II-1-7.
47. 47. Campeau L, Enjalbert M, Lespérance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. N Engl J Med 1984;311:1329-32.
48. 48. Bourassa MG, Campeau L, Lespérance J. Changes in grafts and in coronary arteries after coronary bypass surgery. In: Waters DD, Bourassa MG, editors. Care of the Patient With Previous Coronary Bypass Surgery. Cardiovascular Clinics. Philadelphia: FA Davis, 1991:83-100.
49. 49. Loop FD, Lytle BW, Cosgrove DM, et al. Reoperation for coronary atherosclerosis: changing practice in 2509 consecutive patients. Ann Surg 1990;212:378-86.
50. 50. Lawrie GM, Morris GC, Chapman DW, Winters WL, Lie JT. Patterns of patency of 596 vein grafts up to seven years after aortocoronary bypass. J Thorac Cardiovasc Surg 1977;3:443-8.
51. 51. Lawrie GM, Morris GC Jr, Calhoon JH, et al. Clinical results of coronary bypass in 500 patients at least 10 years after operation. Circulation 1982;66 Suppl I:I-1-5.
52. 52. Lytle BW, Loop FD, Taylor PC, et al. The effect of coronary reoperation on the survival of patients, with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 1993;105:605-12.
53. 53. Lawrie GM, Morris GC, Earle N. Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years. Ann Surg 1991;213:377-87.
54. 54. Rahimtoola SH, Fessler CL, Grunkemeier GL, Starr A. Survival 15 to 20 years after coronary bypass surgery for angina. J Am Coll Cardiol 1993;21: 151-7.
55. 55. Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS Registry study. J Am Coll Cardiol 1995;25:1000-9.
56. 56. Keon WJ, Heggtveit HA, Leduc J. Perioperative myocardial infarction caused by atheroembolism. J Thorac Cardiovasc Surg 1982;84:849-54.
57. 57. Grondin CM. Reoperation in patients with graft disease: pitfalls and rewards. In: Walter PJ, editor. Treatment of end stage coronary artery disease. Adv Cardiol 1988;36:100-9.
58. 58. FitzGibbon GM, Leach AJ, Kafka HP. Atherosclerosis of coronary artery bypass grafts and smoking. Can Med Assoc J 1987;136:45-7.
59. 59. Voors AA, van Brussel BL, Plocker HWT, et al. Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. Circulation 1996;93:42-7.
60. 60. Derby SJ, Scanlon LR, Lewis WF, McMenemy JP, Owen DJ, St. Pierre JJ. Department of National Defence 1987 Smoking Survey. Ottawa (Canada): National Defence Headquarters, 1988.
61. 61. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
62. 62. Pitt B, Mancini GBJ, Ellis SG, Rosman HS, Park J-S, McGovern ME (for the PLAC I investigators). Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC I): Reduction in atherosclerotic progression and clinical events. J Am Coll Cardiol 1995;26:1133-9.
63. 63. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333: 1301-7.
64. 64. Seto TB, Tremble MA, Ginsburg GS. Do we undertreat hyperlipidaemia? The use of lipid-lowering agents in patients with coronary artery disease [abstract]. J Am Coll Cardiol 1996;27 Suppl A:304A.
65. 65. Downey NA, Lee E, Sampsel JM, Sikard G, Kashyap ML, Hagar JM. Treatment of dyslipidaemia in veterans with coronary artery disease-follow-up after NCEP: ATP II [abstract]. J Am Coll Cardiol 1996;27 Suppl A:304A.
66. 66. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6.
67. 67. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts - effects on survival over a 15-year period. N Engl J Med 1996;334:216-9.
68. 68. Loop FD. Internal-thoracic-artery grafts biologically better coronary arteries [editorial]. N Engl J Med 1996;334:263-4.
69. 69. Pym J, Brown PM, Charrette EJP, Parker JO, West RO. Gastroepiploic-coronary anastomosis. A viable alternative bypass graft. J Thorac Cardiovasc Surg 1987;94:256-9.
70. 70. Suma H. Newer arterial coronary bypass conduits: right gastroepiploic and epigastric artery. In: Lüscher TF, Turina M, Braunwald E, editors. Coronary Graft Disease. Mechanisms and Prevention. Berlin, Heidelberg, New York: Springer-Verlag, 1995:70-83.
71. 71. Hedger P. Important updated information for physicians about patients with Bjork-Shiley 60 degree convexo-concave heart valves [Letter]. Irvine (CA): Shiley Heart Valve Research Centre, February 1995.
72. 72. Green J, Wintfeld N. Report cards on cardiac surgeons. Assessing New York State's approach. N Engl J Med 1995;332:1229-32.
73. 73. Epstein A. Performance reports on quality - prototypes, problems, and prospects. N Engl J Med 1995;333:57-61.